Kristensen BW - Search Results

1

Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.

Ferreira MSV, Sørensen MD, Pusch S, Beier D, Bouillon AS, Kristensen BW, Brümmendorf TH, Beier CP, Beier F. Ferreira MSV, et al. Among authors: kristensen bw. J Neurooncol. 2020 Mar;147(1):1-14. doi: 10.1007/s11060-020-03394-y. Epub 2020 Jan 20. J Neurooncol. 2020. PMID: 31960234 Free PMC article.

2

CD133 identifies perivascular niches in grade II-IV astrocytomas.

Christensen K, Schrøder HD, Kristensen BW. Christensen K, et al. Among authors: kristensen bw. J Neurooncol. 2008 Nov;90(2):157-70. doi: 10.1007/s11060-008-9648-8. Epub 2008 Jul 9. J Neurooncol. 2008. PMID: 18612800

3

Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.

Aaberg-Jessen C, Christensen K, Offenberg H, Bartels A, Dreehsen T, Hansen S, Schrøder HD, Brünner N, Kristensen BW. Aaberg-Jessen C, et al. Among authors: kristensen bw. J Neurooncol. 2009 Oct;95(1):117-128. doi: 10.1007/s11060-009-9910-8. Epub 2009 May 9. J Neurooncol. 2009. PMID: 19430729

4

Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids.

Kolenda J, Jensen SS, Aaberg-Jessen C, Christensen K, Andersen C, Brünner N, Kristensen BW. Kolenda J, et al. Among authors: kristensen bw. J Neurooncol. 2011 May;103(1):43-58. doi: 10.1007/s11060-010-0357-8. Epub 2010 Sep 11. J Neurooncol. 2011. PMID: 20835751

5

CD133+ niches and single cells in glioblastoma have different phenotypes.

Christensen K, Schrøder HD, Kristensen BW. Christensen K, et al. Among authors: kristensen bw. J Neurooncol. 2011 Aug;104(1):129-43. doi: 10.1007/s11060-010-0488-y. Epub 2010 Dec 24. J Neurooncol. 2011. PMID: 21184132

6

MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.

Hermansen SK, Dahlrot RH, Nielsen BS, Hansen S, Kristensen BW. Hermansen SK, et al. Among authors: kristensen bw. J Neurooncol. 2013 Jan;111(1):71-81. doi: 10.1007/s11060-012-0992-3. Epub 2012 Oct 28. J Neurooncol. 2013. PMID: 23104517

7

A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1.

Dahlrot RH, Kristensen BW, Hjelmborg J, Herrstedt J, Hansen S. Dahlrot RH, et al. Among authors: kristensen bw. Int J Clin Exp Pathol. 2013;6(1):31-40. Epub 2012 Nov 20. Int J Clin Exp Pathol. 2013. PMID: 23236540 Free PMC article.

8

A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).

Dahlrot RH, Kristensen BW, Hjelmborg J, Herrstedt J, Hansen S. Dahlrot RH, et al. Among authors: kristensen bw. J Neurooncol. 2013 Sep;114(3):309-17. doi: 10.1007/s11060-013-1186-3. Epub 2013 Jul 2. J Neurooncol. 2013. PMID: 23817809

9

Prognostic value of Musashi-1 in gliomas.

Dahlrot RH, Hansen S, Herrstedt J, Schrøder HD, Hjelmborg J, Kristensen BW. Dahlrot RH, et al. Among authors: kristensen bw. J Neurooncol. 2013 Dec;115(3):453-61. doi: 10.1007/s11060-013-1246-8. Epub 2013 Sep 21. J Neurooncol. 2013. PMID: 24057325

10

Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.

Dahlrot RH, Sørensen MD, Rosager AM, Hellwege S, Bangsø JA, Rosenberg T, Petterson SA, Klitkou J, Fosmark S, Hansen S, Kristensen BW. Dahlrot RH, et al. Among authors: kristensen bw. CNS Oncol. 2014 Jul;3(4):287-98. doi: 10.2217/cns.14.30. CNS Oncol. 2014. PMID: 25286040 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters